Medication info
Hyuniz Valsartan Tablets 10/160mg (Amlodipine, Valsartan)

Hyuniz Valsartan Tablets 10/160mg (Amlodipine, Valsartan)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Huons Meditech Co., Ltd.
Appearance
Bright yellow oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201503874 · Approved 2015.06.15 · Insurance code 670400990

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using either component, a direct switch to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance ≥10mL/min). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance <10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Child dose
Pediatric patients under 18 years of age: Use of this medicine is not recommended because its safety and efficacy have not been established.

Ingredients

Manufacturer
Huons Meditech Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively manage blood pressure in patients with essential hypertension where blood pressure is not adequately controlled by either amlodipine or valsartan alone.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using either component, a direct switch to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance ≥10mL/min). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance <10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.

Child dose

Pediatric patients under 18 years of age: Use of this medicine is not recommended because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients who are allergic to the ingredients contained in this medication, pregnant or breastfeeding women, patients with severe renal or hepatic impairment, and those with certain heart conditions should not take this medication. Patients with low sodium or fluid levels may experience hypotension when taking this medication, so it is important to carefully control their condition before taking it and monitor blood pressure and condition closely while taking it. Patients with high potassium levels should frequently check their potassium levels when taking this medication in combination with other drugs that increase potassium, and patients with poor kidney function also need to take caution. Patients with kidney transplants or renal artery stenosis should be carefully monitored since this medication can affect kidney function. If symptoms of angioedema (swelling of the face, lips, tongue, etc.) occur while taking this medication, it should be discontinued immediately and medical advice sought. Patients with heart failure or following myocardial infarction should have their heart and kidney function regularly evaluated while taking this medication, and acute myocardial infarction patients should also be cautious. Taking this medication in conjunction with other antihypertensives can increase the risk of hypotension, worsening kidney function, and hyperkalemia, so it is necessary to inform healthcare providers about concomitant medications and ensure regular monitoring. Caution should be exercised as dizziness or fatigue may occur while driving or operating machinery. In case of overdose, severe hypotension or arrhythmia may occur, so it is important to adhere to the prescribed dosage, and if symptoms arise, seek medical attention immediately. This medication is not recommended for children under 18 years of age, and elderly patients may take the same dose as adults but need to be closely monitored. Patients with impaired liver function may need adjustments to their medication dose, and it is advisable to monitor liver function test results during treatment.

Side effects

  • Pharyngitis
  • influenza
  • hypersensitivity
  • visual impairment
  • anxiety
  • headache
  • dizziness
  • drowsiness
  • positional dizziness
  • paresthesia
Show 108 more
  • vertigo
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • throat and laryngeal pain
  • diarrhea
  • nausea
  • abdominal pain
  • constipation
  • dry mouth
  • rash
  • erythema
  • diaphoresis
  • pruritus
  • joint swelling
  • low back pain
  • arthritis
  • muscle spasms
  • lethargy
  • polyuria
  • nocturia
  • erectile dysfunction
  • edema
  • local edema
  • facial edema
  • peripheral edema
  • fatigue
  • flushing
  • asthenia
  • facial flushing
  • hemoglobin decrease
  • hematocrit decrease
  • neutropenia
  • thrombocytopenia
  • serum sickness
  • serum potassium increase
  • vasculitis
  • elevated liver function tests
  • angioedema
  • myalgia
  • renal failure
  • renal injury
  • increased serum creatinine
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory infection
  • viral infection
  • diplopia
  • thrombocytopenia
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • mood changes
  • tremors
  • sensory loss
  • dysgeusia
  • peripheral neuropathy
  • hypertonia
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • vasculitis
  • dyspnea
  • rhinitis
  • vomiting
  • dyspepsia
  • pancreatitis
  • gastritis
  • gingival hyperplasia
  • hepatitis
  • jaundice
  • alopecia
  • purpura
  • skin depigmentation
  • photosensitivity
  • angioedema
  • urticaria
  • erythema multiforme
  • Stevens-Johnson syndrome
  • myalgia
  • voiding dysfunction
  • enuresis
  • gynecomastia
  • pain
  • malaise
  • chest pain
  • weight loss
  • weight gain
  • increased liver enzymes
  • chest discomfort
  • abdominal discomfort
  • gastroesophageal reflux disease
  • neck pain
  • hypercholesterolemia
  • hypoglycemia
  • neuropathy
  • sensory loss
  • Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1°C and 30°C to ensure the medication's efficacy is preserved for a longer duration.

Appearance and packaging

Appearance

Bright yellow oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.